Transient Elastography Global Market Report 2025

The transient elastography market size has grown rapidly in recent years. It will grow from $1.27 billion in 2024 to $1.44 billion in 2025 at a compound annual growth rate (CAGR) of 13.4%. Growth in the historic period can be attributed to increased government initiatives, a favorable regulatory environment, rising sedentary lifestyles, higher alcohol consumption, and growing per-capita income expenditures.

The transient elastography market size is expected to see rapid growth in the next few years. It will grow to $2.35 billion in 2029 at a compound annual growth rate (CAGR) of 13.1%. Growth in the forecast period can be linked to rising demand for non-invasive diagnostics, improved access to healthcare infrastructure, increasing awareness of early liver disease detection, a shift toward value-based healthcare, and a stronger emphasis on early diagnosis. Major trends expected during the forecast period include technological advancements in miniaturized devices, integration of elastography with digital health records and telemedicine platforms, innovations in portable device technology, AI-driven analytics, and continued technological progress in portable devices.

The increasing prevalence of chronic liver diseases is expected to drive growth in the transient elastography market in the coming years. Chronic liver disease is a long-term, progressive condition in which the liver becomes damaged, leading to gradual functional decline due to persistent inflammation or scarring. Excessive alcohol consumption is a major factor contributing to liver fibrosis and cirrhosis, heightening the need for regular liver health monitoring. The rising burden of alcohol-related liver damage, along with other chronic liver conditions, is fueling demand for transient elastography as a non-invasive method to measure liver stiffness and detect early signs of liver deterioration. For example, in April 2024, GOV.UK reported that hospital admissions due to liver disease in the U.K. continue to rise. In the financial year ending 2023, admissions increased to 155.2 (152.9-157.5) per 100,000 population, up from 150.6 (148.2-152.9) per 100,000 the previous year. Therefore, the growing prevalence of chronic liver diseases is driving growth in the transient elastography market.

Key companies in the transient elastography market are developing innovations such as visual transient elastography to provide real-time visualization of liver tissue stiffness, improve diagnostic accuracy, and support earlier detection and monitoring of liver diseases through non-invasive imaging. Visual transient elastography is a non-invasive technique that combines ultrasound with elastography to visually measure and map liver tissue stiffness in real time. For instance, in June 2023, Mindray, a China-based medical device manufacturer, launched the Hepatus 6 Diagnostic Ultrasound System. The Hepatus 6 integrates transient elastography with real-time 2D diagnostic ultrasound on a single platform, enabling non-invasive liver disease assessment. Its “Visual Transient Elastography (ViTE)” technology quantifies liver fibrosis and steatosis while simultaneously providing ultrasound imaging. The system is specifically designed for liver evaluation, streamlining disease detection, diagnosis, and monitoring.

In June 2025, Tawazun Health, a U.K.-based provider of community and holistic healthcare services, partnered with LiverScan Group for an undisclosed amount. Through this partnership, Tawazun Health aims to expand access to FibroScan transient elastography services across the U.K., improving early detection and management of liver diseases by enhancing service reach and clinical integration. LiverScan Group is a U.K.-based company specializing in liver health assessment and disease identification using transient elastography technology.

Major companies operating in the transient elastography market are Siemens Healthcare GmbH, GE HealthCare Technologies Inc., Mindray Bio-Medical Electronics Co. Ltd., Tawazun Health Ltd., Echosens SA., CHISON Medical Technologies Co. Ltd., Neusoft Medical Systems Co. Ltd., Hisky Medical, Wuxi Hisky Medical Technologies Co. Ltd., Nexgen Therapeutics, Liver Scan Group Limited, Eieling Technology Limited, SMEDA Medical Co. Ltd., Sandhill Scientific Inc.

North America was the largest region in the transient elastography market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in transient elastography report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the transient elastography market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

The transient elastography market research report is one of a series of new reports that provides transient elastography market statistics, including transient elastography industry global market size, regional shares, competitors with a transient elastography market share, detailed transient elastography market segments, market trends and opportunities, and any further data you may need to thrive in the transient elastography industry. This transient elastography market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Transient elastography is a non-invasive medical device that measures liver stiffness using painless, ultrasound-based technology. It is widely used by physicians to evaluate liver health and detect conditions such as fibrosis and cirrhosis at an early stage. The device delivers quick and reliable results without requiring a biopsy, helping enhance patient care by enabling routine monitoring of liver disease progression.

The main products in transient elastography include standalone devices and portable devices. Transient elastography standalone devices are non-invasive medical instruments that assess liver stiffness and fat content by delivering a painless mechanical vibration into the liver and measuring the speed of the resulting shear wave. The various applications include liver disease assessment, hepatitis, fibrosis, cirrhosis, and other related uses, serving hospitals, diagnostic centers, research institutes, and other end users.

The transient elastography market consists of sales of fibroscan, hepatus 6 diagnostic ultrasound system, aixplorer ultimate, resona 7 ultrasound system, and logiq e10 series. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.